Novavax (NVAX) Says FDA Requested Additional Clinical Data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 11.20 -0.23 (2.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.43 | 52 Week High | $9.23 | |||
| Open | $11.39 | 52 Week Low | $1.16 | |||
| Day High | $11.46 | P/E | N/A | |||
| Day Low | $11.00 | EPS | $-0.30 | |||
| Volume | 2,771,790 | |||||
